Market Cap 1.15B
Revenue (ttm) 731.97M
Net Income (ttm) 159.52M
EPS (ttm) N/A
PE Ratio 8.01
Forward PE 7.95
Profit Margin 21.79%
Debt to Equity Ratio 0.80
Volume 220,700
Avg Vol 428,814
Day's Range N/A - N/A
Shares Out 46.50M
Stochastic %K 81%
Beta 0.75
Analysts Sell
Price Target $32.50

Company Profile

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxon...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 909 980 9484
Address:
11570 6th Street, Rancho Cucamonga, United States
EquityInvest
EquityInvest Oct. 23 at 4:16 AM
Panish | Shea | Ravipudi LLP Obtains $34.1 Million Verdict for Pedestrian Severely Injured by Driver Who Ran a Red Light - Business Wire $AMPH https://stocks.apple.com/Ax4kxlLLvSTu8JXXO0y9FOQ
0 · Reply
anachartanalyst
anachartanalyst Oct. 22 at 11:01 AM
$AMPH https://anachart.com/wp-content/uploads/ana_temp/1761130885_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 10:51 AM
Needham has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Buy with a target price of 36.
0 · Reply
Arcides
Arcides Oct. 10 at 7:20 PM
$AMPH most of that bounce is gone...
0 · Reply
JarvisFlow
JarvisFlow Oct. 5 at 12:35 PM
JP Morgan has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Overweight with a target price of 60 → 45.
0 · Reply
Arcides
Arcides Oct. 3 at 3:57 PM
$AMPH this was clearly rejected at 200dma, 10, 21 and 200 days moving averages are pointing down, 50dma points up will it hold that level for a while or break down again?
0 · Reply
NYBomba
NYBomba Oct. 1 at 5:21 PM
$AMPH - incoming Golden Cross, should happen by Monday, GLTA
0 · Reply
EquityInvest
EquityInvest Sep. 15 at 3:15 PM
$AMPH short!!!!
0 · Reply
FloatWanderer
FloatWanderer Sep. 15 at 6:36 AM
$AMPH Earnings variability expected; long-term thesis hinges on scale
0 · Reply
TalkMarkets
TalkMarkets Sep. 12 at 6:33 PM
#Volatility Ahead? Asset Managers Are Shorting The S&P 500 $SMCI $SPY $AMPH $WING $HIMS https://talkmarkets.com/content/etfs/volatility-ahead-asset-managers-are-shorting-the-sp-500?post=522515
0 · Reply
Latest News on AMPH
After Protracted Sell-Off, Amphastar Looks Like A Value Pick

Sep 23, 2025, 10:06 AM EDT - 4 weeks ago

After Protracted Sell-Off, Amphastar Looks Like A Value Pick


Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Aug 11, 2025, 6:00 AM EDT - 2 months ago

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP


Amphastar Pharmaceuticals: Navigating Through An Inflection Year

May 11, 2025, 11:32 AM EDT - 5 months ago

Amphastar Pharmaceuticals: Navigating Through An Inflection Year


Top 2 Health Care Stocks That May Rocket Higher This Month

Feb 21, 2025, 2:17 PM EST - 8 months ago

Top 2 Health Care Stocks That May Rocket Higher This Month

WST


Amphastar Pharmaceuticals: A Gradual Strategy

Feb 19, 2025, 1:09 PM EST - 8 months ago

Amphastar Pharmaceuticals: A Gradual Strategy


Amphastar Pharmaceuticals: Cheap With Caveats

Jan 3, 2025, 12:48 PM EST - 10 months ago

Amphastar Pharmaceuticals: Cheap With Caveats


6 Beaten Down Stocks Rated Buy (SA Quant)

Aug 19, 2024, 5:00 AM EDT - 1 year ago

6 Beaten Down Stocks Rated Buy (SA Quant)

CAAP CCL STRL TCOM TWLO


EquityInvest
EquityInvest Oct. 23 at 4:16 AM
Panish | Shea | Ravipudi LLP Obtains $34.1 Million Verdict for Pedestrian Severely Injured by Driver Who Ran a Red Light - Business Wire $AMPH https://stocks.apple.com/Ax4kxlLLvSTu8JXXO0y9FOQ
0 · Reply
anachartanalyst
anachartanalyst Oct. 22 at 11:01 AM
$AMPH https://anachart.com/wp-content/uploads/ana_temp/1761130885_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 10:51 AM
Needham has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Buy with a target price of 36.
0 · Reply
Arcides
Arcides Oct. 10 at 7:20 PM
$AMPH most of that bounce is gone...
0 · Reply
JarvisFlow
JarvisFlow Oct. 5 at 12:35 PM
JP Morgan has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Overweight with a target price of 60 → 45.
0 · Reply
Arcides
Arcides Oct. 3 at 3:57 PM
$AMPH this was clearly rejected at 200dma, 10, 21 and 200 days moving averages are pointing down, 50dma points up will it hold that level for a while or break down again?
0 · Reply
NYBomba
NYBomba Oct. 1 at 5:21 PM
$AMPH - incoming Golden Cross, should happen by Monday, GLTA
0 · Reply
EquityInvest
EquityInvest Sep. 15 at 3:15 PM
$AMPH short!!!!
0 · Reply
FloatWanderer
FloatWanderer Sep. 15 at 6:36 AM
$AMPH Earnings variability expected; long-term thesis hinges on scale
0 · Reply
TalkMarkets
TalkMarkets Sep. 12 at 6:33 PM
#Volatility Ahead? Asset Managers Are Shorting The S&P 500 $SMCI $SPY $AMPH $WING $HIMS https://talkmarkets.com/content/etfs/volatility-ahead-asset-managers-are-shorting-the-sp-500?post=522515
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 5 at 9:44 PM
$AMPH Excellent article that nails exactly where AMPH stands right now. So if you want to update your AMPH knowledge or get acquainted with AMPH, this is a must read. https://beyondspx.com/quote/AMPH/amphastar-s-strategic-ascent-branded-powerhouses-and-a-robust-pipeline-drive-future-growth-nasdaq-amph#analysis
0 · Reply
NYBomba
NYBomba Sep. 2 at 5:23 PM
$AMPH - great looking chart, just on technicals, I'd say the price range will step higher ...
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 2 at 8:11 AM
$AMPH Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection By Laiba Immad | September 02, 2025, 4:06 AM
0 · Reply
JarvisFlow
JarvisFlow Aug. 26 at 3:23 PM
B of A Securities has updated their rating for Amphastar Pharma ( $AMPH ) to Neutral with a price target of 32.
0 · Reply
PatternWatcher
PatternWatcher Aug. 23 at 5:31 AM
$AMPH Amphastar Pharmaceuticals produces generic injectables facing pricing pressure and regulatory scrutiny
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 18 at 1:24 PM
$AMPH Amphenol to Buy Trexon From Audax Private Equity for $1 Billion - WSJ https://ooc.bz/l/74299
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Aug. 12 at 8:02 PM
$AMPH someone has been buying
0 · Reply
Estimize
Estimize Aug. 12 at 8:00 PM
Wall St is expecting 0.86 EPS for $AMPH Q3 [Reporting 11/10 AMC] http://www.estimize.com/intro/amph?chart=historical&metric_name=eps&utm_co
0 · Reply
topstockalerts
topstockalerts Aug. 12 at 1:30 PM
$AMPH she wants to move higher..
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 12:30 PM
Needham updates rating for Amphastar Pharma ( $AMPH ) to Buy, target set at 36.
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 12 at 12:24 PM
$AMPH (+4.8% pre) Amphastar licenses three peptide drugs from Nanjing Anji for $453 million - SI https://ooc.bz/l/73591
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 12 at 10:13 AM
WATCHLIST AUG 12 2025 $ALGT Allegiant Expands Growing Network With New Service To Huntsville International Airport And Multiple Florida Destinations $SMR Canaccord Genuity Maintains Buy on NuScale Power, Raises Price Target to $44 $KLTO Klotho Neurosciences (KLTO) Begins KLTO-202 Gene Therapy Manufacturing Using AAVnerGene's AAVone And ATHENA Platform Technologies $AMPH Amphastar Pharmaceuticals Signs $453M Exclusive Licensing Deal With Nanjing Anji For Three Proprietary Peptides In Oncology And Ophthalmology $HITI High Tide (HITI) Updates On German Medical Cannabis Deal, Appoints VP Digital & eCommerce, Files C$100M Shelf Prospectus, Hires IR Agency
0 · Reply